
Breakthrough Gene Therapy for Hemophilia B in China
China approves BBM-H901, its first gene therapy for hemophilia B, marking a new era in personalized healthcare.
Stay informed, stay connected—news for amigos everywhere.
China approves BBM-H901, its first gene therapy for hemophilia B, marking a new era in personalized healthcare.